Gefitinib-induced skin ulceration in metastatic adenocarcinoma lung

Abstract We report a case of gefitinib-induced skin ulceration in a 50-year-old female with metastatic adenocarcinoma of lung who developed this adverse effect 2 weeks following initiation of gefitinib at a dose of 250 mg/day. The ulcer improved with stopping gefitinib for 2 weeks and also addition...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Indian journal of medical and paediatric oncology 2014-01, Vol.35 (1), p.109-110
Hauptverfasser: Sathyanarayanan, Vishwanath, Lokesh, Kadabur Nagendrappa, Channaviriappa, Lakshmaiah Kuntejowdahalli, Jacob, Linu Abraham
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 110
container_issue 1
container_start_page 109
container_title Indian journal of medical and paediatric oncology
container_volume 35
creator Sathyanarayanan, Vishwanath
Lokesh, Kadabur Nagendrappa
Channaviriappa, Lakshmaiah Kuntejowdahalli
Jacob, Linu Abraham
description Abstract We report a case of gefitinib-induced skin ulceration in a 50-year-old female with metastatic adenocarcinoma of lung who developed this adverse effect 2 weeks following initiation of gefitinib at a dose of 250 mg/day. The ulcer improved with stopping gefitinib for 2 weeks and also addition of topical steroids and antibiotics. We are reporting this case to create awareness among treating oncologists of this adverse effect and also prompt interruption of therapy and topical steroids/antibiotics is useful to treat this adverse event.
doi_str_mv 10.4103/0971-5851.133736
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4080647</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A370360016</galeid><sourcerecordid>A370360016</sourcerecordid><originalsourceid>FETCH-LOGICAL-c529t-46f20c42c0426093b771019ce571b273a07cb4d023d26b848de0ce757f2df82d3</originalsourceid><addsrcrecordid>eNp1UU1v1DAUjBAVLS13TigSErdsn7-TC1K1goJUqRd6thzb2XVJ7GI7lfj3OKSUXQnkg_3emxn5zVTVWwQbioBcQidQw1qGNogQQfiL6qy0WIMR7l7-fq_j0-p1SvcAhCHevqpOMQPguOvOqu21HVx23vWN82bW1tTpu_P1PGobVXbB16WabFYpl1LXylgftIra-TCpepz97qI6GdSY7Jun-7y6-_zp2_ZLc3N7_XV7ddNohrvcUD5g0BRroJhDR3ohEKBOWyZQjwVRIHRPDWBiMO9b2hoL2gomBmyGFhtyXn1cdR_mfrJGW5-jGuVDdJOKP2VQTh5PvNvLXXiUFFrgVBSB908CMfyYbcryPszRlz9LxAhFBLOW_0Xt1Gil80MoYnpyScsrIoBwALSgNv9AlWPs5HTwxdbSPyJ8OCDsrRrzPoVxXjxOx0BYgTqGlKIdnjdEIJfY5ZKrXHKVa-yF8u7QmWfCn5wL4HIF5L2zkz3Y-3-SvwDfTrOm</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1534132586</pqid></control><display><type>article</type><title>Gefitinib-induced skin ulceration in metastatic adenocarcinoma lung</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>Thieme Connect Journals Open Access</source><source>PubMed Central</source><creator>Sathyanarayanan, Vishwanath ; Lokesh, Kadabur Nagendrappa ; Channaviriappa, Lakshmaiah Kuntejowdahalli ; Jacob, Linu Abraham</creator><creatorcontrib>Sathyanarayanan, Vishwanath ; Lokesh, Kadabur Nagendrappa ; Channaviriappa, Lakshmaiah Kuntejowdahalli ; Jacob, Linu Abraham</creatorcontrib><description>Abstract We report a case of gefitinib-induced skin ulceration in a 50-year-old female with metastatic adenocarcinoma of lung who developed this adverse effect 2 weeks following initiation of gefitinib at a dose of 250 mg/day. The ulcer improved with stopping gefitinib for 2 weeks and also addition of topical steroids and antibiotics. We are reporting this case to create awareness among treating oncologists of this adverse effect and also prompt interruption of therapy and topical steroids/antibiotics is useful to treat this adverse event.</description><identifier>ISSN: 0971-5851</identifier><identifier>EISSN: 0975-2129</identifier><identifier>DOI: 10.4103/0971-5851.133736</identifier><identifier>PMID: 25006299</identifier><language>eng</language><publisher>A-12, 2nd Floor, Sector 2, Noida-201301 UP, India: Thieme Medical and Scientific Publishers Pvt. Ltd</publisher><subject>Adenocarcinoma ; Antibiotics ; CASE REPORT ; Case studies ; Complications and side effects ; Epidermal growth factor ; Gefitinib ; Lung cancer ; Metastasis ; Mutation ; Skin ; Ulcers</subject><ispartof>Indian journal of medical and paediatric oncology, 2014-01, Vol.35 (1), p.109-110</ispartof><rights>Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)</rights><rights>COPYRIGHT 2014 Medknow Publications and Media Pvt. Ltd.</rights><rights>Copyright Medknow Publications &amp; Media Pvt Ltd Jan-Mar 2014</rights><rights>Copyright: © Indian Journal of Medical and Paediatric Oncology 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c529t-46f20c42c0426093b771019ce571b273a07cb4d023d26b848de0ce757f2df82d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080647/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080647/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,20890,27923,27924,53790,53792,54586</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25006299$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sathyanarayanan, Vishwanath</creatorcontrib><creatorcontrib>Lokesh, Kadabur Nagendrappa</creatorcontrib><creatorcontrib>Channaviriappa, Lakshmaiah Kuntejowdahalli</creatorcontrib><creatorcontrib>Jacob, Linu Abraham</creatorcontrib><title>Gefitinib-induced skin ulceration in metastatic adenocarcinoma lung</title><title>Indian journal of medical and paediatric oncology</title><addtitle>Indian J Med Paediatr Oncol</addtitle><description>Abstract We report a case of gefitinib-induced skin ulceration in a 50-year-old female with metastatic adenocarcinoma of lung who developed this adverse effect 2 weeks following initiation of gefitinib at a dose of 250 mg/day. The ulcer improved with stopping gefitinib for 2 weeks and also addition of topical steroids and antibiotics. We are reporting this case to create awareness among treating oncologists of this adverse effect and also prompt interruption of therapy and topical steroids/antibiotics is useful to treat this adverse event.</description><subject>Adenocarcinoma</subject><subject>Antibiotics</subject><subject>CASE REPORT</subject><subject>Case studies</subject><subject>Complications and side effects</subject><subject>Epidermal growth factor</subject><subject>Gefitinib</subject><subject>Lung cancer</subject><subject>Metastasis</subject><subject>Mutation</subject><subject>Skin</subject><subject>Ulcers</subject><issn>0971-5851</issn><issn>0975-2129</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>0U6</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp1UU1v1DAUjBAVLS13TigSErdsn7-TC1K1goJUqRd6thzb2XVJ7GI7lfj3OKSUXQnkg_3emxn5zVTVWwQbioBcQidQw1qGNogQQfiL6qy0WIMR7l7-fq_j0-p1SvcAhCHevqpOMQPguOvOqu21HVx23vWN82bW1tTpu_P1PGobVXbB16WabFYpl1LXylgftIra-TCpepz97qI6GdSY7Jun-7y6-_zp2_ZLc3N7_XV7ddNohrvcUD5g0BRroJhDR3ohEKBOWyZQjwVRIHRPDWBiMO9b2hoL2gomBmyGFhtyXn1cdR_mfrJGW5-jGuVDdJOKP2VQTh5PvNvLXXiUFFrgVBSB908CMfyYbcryPszRlz9LxAhFBLOW_0Xt1Gil80MoYnpyScsrIoBwALSgNv9AlWPs5HTwxdbSPyJ8OCDsrRrzPoVxXjxOx0BYgTqGlKIdnjdEIJfY5ZKrXHKVa-yF8u7QmWfCn5wL4HIF5L2zkz3Y-3-SvwDfTrOm</recordid><startdate>201401</startdate><enddate>201401</enddate><creator>Sathyanarayanan, Vishwanath</creator><creator>Lokesh, Kadabur Nagendrappa</creator><creator>Channaviriappa, Lakshmaiah Kuntejowdahalli</creator><creator>Jacob, Linu Abraham</creator><general>Thieme Medical and Scientific Publishers Pvt. Ltd</general><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications &amp; Media Pvt. Ltd</general><general>Medknow Publications &amp; Media Pvt Ltd</general><scope>0U6</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PADUT</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>5PM</scope></search><sort><creationdate>201401</creationdate><title>Gefitinib-induced skin ulceration in metastatic adenocarcinoma lung</title><author>Sathyanarayanan, Vishwanath ; Lokesh, Kadabur Nagendrappa ; Channaviriappa, Lakshmaiah Kuntejowdahalli ; Jacob, Linu Abraham</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c529t-46f20c42c0426093b771019ce571b273a07cb4d023d26b848de0ce757f2df82d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adenocarcinoma</topic><topic>Antibiotics</topic><topic>CASE REPORT</topic><topic>Case studies</topic><topic>Complications and side effects</topic><topic>Epidermal growth factor</topic><topic>Gefitinib</topic><topic>Lung cancer</topic><topic>Metastasis</topic><topic>Mutation</topic><topic>Skin</topic><topic>Ulcers</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sathyanarayanan, Vishwanath</creatorcontrib><creatorcontrib>Lokesh, Kadabur Nagendrappa</creatorcontrib><creatorcontrib>Channaviriappa, Lakshmaiah Kuntejowdahalli</creatorcontrib><creatorcontrib>Jacob, Linu Abraham</creatorcontrib><collection>Thieme Connect Journals Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Research Library China</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Indian journal of medical and paediatric oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sathyanarayanan, Vishwanath</au><au>Lokesh, Kadabur Nagendrappa</au><au>Channaviriappa, Lakshmaiah Kuntejowdahalli</au><au>Jacob, Linu Abraham</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gefitinib-induced skin ulceration in metastatic adenocarcinoma lung</atitle><jtitle>Indian journal of medical and paediatric oncology</jtitle><addtitle>Indian J Med Paediatr Oncol</addtitle><date>2014-01</date><risdate>2014</risdate><volume>35</volume><issue>1</issue><spage>109</spage><epage>110</epage><pages>109-110</pages><issn>0971-5851</issn><eissn>0975-2129</eissn><abstract>Abstract We report a case of gefitinib-induced skin ulceration in a 50-year-old female with metastatic adenocarcinoma of lung who developed this adverse effect 2 weeks following initiation of gefitinib at a dose of 250 mg/day. The ulcer improved with stopping gefitinib for 2 weeks and also addition of topical steroids and antibiotics. We are reporting this case to create awareness among treating oncologists of this adverse effect and also prompt interruption of therapy and topical steroids/antibiotics is useful to treat this adverse event.</abstract><cop>A-12, 2nd Floor, Sector 2, Noida-201301 UP, India</cop><pub>Thieme Medical and Scientific Publishers Pvt. Ltd</pub><pmid>25006299</pmid><doi>10.4103/0971-5851.133736</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0971-5851
ispartof Indian journal of medical and paediatric oncology, 2014-01, Vol.35 (1), p.109-110
issn 0971-5851
0975-2129
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4080647
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; Thieme Connect Journals Open Access; PubMed Central
subjects Adenocarcinoma
Antibiotics
CASE REPORT
Case studies
Complications and side effects
Epidermal growth factor
Gefitinib
Lung cancer
Metastasis
Mutation
Skin
Ulcers
title Gefitinib-induced skin ulceration in metastatic adenocarcinoma lung
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T03%3A14%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gefitinib-induced%20skin%20ulceration%20in%20metastatic%20adenocarcinoma%20lung&rft.jtitle=Indian%20journal%20of%20medical%20and%20paediatric%20oncology&rft.au=Sathyanarayanan,%20Vishwanath&rft.date=2014-01&rft.volume=35&rft.issue=1&rft.spage=109&rft.epage=110&rft.pages=109-110&rft.issn=0971-5851&rft.eissn=0975-2129&rft_id=info:doi/10.4103/0971-5851.133736&rft_dat=%3Cgale_pubme%3EA370360016%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1534132586&rft_id=info:pmid/25006299&rft_galeid=A370360016&rfr_iscdi=true